![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cap-xx Limited | LSE:CPX | London | Ordinary Share | AU0000XINAS1 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.032 | 40.51% | 0.111 | 0.107 | 0.115 | 0.1175 | 0.081 | 0.08 | 1,012,738,594 | 11:15:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Capacitors | 3.63M | -5.56M | -0.0077 | -0.14 | 792.21k |
Date | Subject | Author | Discuss |
---|---|---|---|
15/11/2023 21:18 | Flurry of filings and final pre trial conference on Friday. So we enter the pre-trial settlement zone... | ![]() bagpuss67 | |
10/11/2023 07:51 | post 7145 by Scrutable. I had your number then, and have been proved right. You talk the talk, but are out of your depth "Your contempt for marketing as an overlooked guide to a company's success is risible. If you can spot a company with marketing superior to its peers, it either supports a more profitable pricing structure and/or increasing volumes sold. Marketing is often incorrectly assumed to be identical to advertising and communications without understanding the key role it plays in developing a product or service of higher quality than competition. Judging a company by its superiority in marketing gives you 1-2 years advance on the future trend of profitability. Sneer at this insight to your own disadvantage." | ![]() jailbird | |
07/11/2023 20:24 | Gary Buffet with cutting edge commentary there. | ![]() bagpuss67 | |
07/11/2023 19:29 | 11/07/2023ORAL ORDER Re-Setting Scheduling Order Deadlines (The Final Pretrial Conference is rescheduled for 11/17/2023 at 01:00 PM in Courtroom 4B before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 11/7/2023. (Text entry; no document attached.) 11/07/2023Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 11/7/2023. (Court Reporter Deanna Warner.) (Text entry; no document attached.) | ![]() globalwill | |
07/11/2023 17:10 | Sorry I don't offer a translation service - I'd have to charge commission for that. | ![]() pepperedlikeasteak | |
07/11/2023 16:43 | Pepper Any chance you could translate Gary's post. | ![]() grahamwales | |
07/11/2023 14:02 | PepperedLikeASteak, don’t forget CPX have increased payments on product revenue to be added each month to be included! | ![]() garybrandon | |
07/11/2023 11:09 | I suppose they could issue shares instead but would have to be at much lower SP | ![]() grahamwales | |
07/11/2023 11:07 | In addition, the Board anticipates that the Company will be in receipt of a Federal Government R&D tax rebate of approximately A$2.1 million, with these funds expected to be received before the end of the current calendar year, of which A$1.0 million has been drawn down against a revolving line of credit secured by the R&D tax rebate. | ![]() grahamwales | |
07/11/2023 11:03 | It's A2.1m : "Cash to benefit from Australian R&D payment. CAP-XX current cash reserves are approximately A$0.5m, but it is expecting a payment of A$2.1m in the coming weeks for its Australian Tax R&D Rebate for 2022/23." | ![]() pepperedlikeasteak | |
07/11/2023 10:56 | So if they get 1 million from R&D added to the 0.5 million gives them 1.5 million. Cash burn over last 4 months has been 0.5 million per month with CPX saying October is normally the best month. December will be slow due to hols so expect lower revenue in next 4 months compared to last. Yet cavendish saying they will have sufficient cash to last through 2024. Perhaps they know something shareholders don’t 🤔 | ![]() grahamwales | |
07/11/2023 09:54 | From Cavendish note this morning: "Funded even on current run rates. Whilst the revenue run rate for October is in-line with our current expectations, the run rate for the first four months is indicating revenues are likely to be below our current expectations, which were formed under the previous management. Unfortunately, new CEO Lars has not yet completed his sales pipeline review and so we are not able to update expectations against which Lars will be benchmarked. In cash terms, the R&D tax credit should provide the company runway all through FY24E, even at the current run rate (eg, cA$5m for FY23E based on current run rate). However, we believe revenues will start to accelerate in CY24E with Lars’s new sales and distribution strategy and appointments start to bear fruit. With the turnaround showing its first green shoots, and potentially significant upside from IP infringement, we believe the future is looking increasingly positive for CAP-XX." Perhaps Graham should start his own research company to put negative spin on everything ;) | ![]() pepperedlikeasteak | |
07/11/2023 08:33 | Yes dont forget this case was meant to be done and dusted months ago. It unfortunately got delayed and left a gap in the finances prior to receipt of the next R&D credit. I think they could have been more imaginative in terms of how to bring in new money without dilution to long term holders. | ![]() meijiman | |
07/11/2023 08:26 | If they get the initial win I don’t suppose they would need another loan though | ![]() grahamwales | |
07/11/2023 08:24 | So they decided to dilute shareholders instead 😂 | ![]() grahamwales | |
07/11/2023 06:48 | The point I was making was that the terms of that litigation funding may improve after an initial win and that might become a more vibale option to handle the appeal and counter claim. Not sure if litigation funders will join a case part way through though. I'm sure our resident Warren Bufffet will have those facts to hand | ![]() bagpuss67 | |
06/11/2023 22:34 | It's in the Cenkos note from 28 Feb 2023: "...and it is therefore viewing third-party funding terms as highly dilutive to a potential award..." | ![]() pepperedlikeasteak | |
06/11/2023 15:45 | Pepper Where did you find that info | ![]() grahamwales | |
06/11/2023 13:45 | When posters come on asking ridiculously simple questions that the basic research Will cover, I just filler them now ! | ![]() garybrandon | |
06/11/2023 13:38 | Yes, refused by CAP-XX because the funder was asking for too much percent of the pay out. | ![]() pepperedlikeasteak | |
06/11/2023 12:42 | I believe funding was refused. | ![]() grahamwales | |
06/11/2023 10:19 | Sorry I'm newish to this. Have they got litigation funding. Perhaps a win in the first instance will enable a bigger and better litigation funding package | ![]() bagpuss67 | |
06/11/2023 09:57 | You also have to consider the counter claim against CPX. CPX have to win both to survive lose or draw and they will be out on money. | ![]() grahamwales |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions